As BPH has been associated with TGF-β-mediated epithelial-to-mesenchymal transition (EMT)12, we performed immunohistochemical (IHC) staining for E-cadherin and TGF-β (Fig. 3B). The gene discussed is CDH1; the disease is benign prostatic hyperplasia.